Manufacturer: Roche Products India Pvt Ltd
Salt Composition: Ado-trastuzumab emtansine (160mg)
Medicine Type: allopathy
Introduction: In Early Breast cancer Kadcyla 160mg Injection helps to treat initial stages of breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kadcyla 160mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you. In Metastatic breast cancer Kadcyla 160mg Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. This medicine is used when other medicines have not shown significant improvement and the cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kadcyla 160mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Benefits: Your doctor or nurse will give you this medicine. Kindly do not self administer.
Description: Kadcyla 160mg Injection is used in the treatment of early as well as metastatic breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines. Kadcyla 160mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. The most common side effects of this medicine include tiredness, nausea, musculoskeletal (bone, muscle or joint) pain, and bleeding. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. "There is a Patient Support Program / Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details."
How to Use: Kadcyla 160mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body's immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.
Safety Advice: - Alcohol : CONSULT YOUR DOCTOR - It is not known whether it is safe to consume alcohol with Kadcyla 160mg Injection. Please consult your doctor. - Pregnancy : CONSULT YOUR DOCTOR - Kadcyla 160mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor. - Breast feeding : UNSAFE - Kadcyla 160mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. - Driving : SAFE - Kadcyla 160mg Injection does not usually affect your ability to drive. - Kidney : CONSULT YOUR DOCTOR - There is limited information available on the use of Kadcyla 160mg Injection in patients with kidney disease. Please consult your doctor. - Liver : CAUTION - Kadcyla 160mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Kadcyla 160mg Injection may be needed. Please consult your doctor.
If Missed: If you miss a dose of Kadcyla 160mg Injection, please consult your doctor.
Packaging: Vial
Packaging Type:
Primary Use: Early Breast cancer | Metastatic breast cancer
Side Effects: Nausea | Musculoskeletal (bone, muscle or joint) pain | Bleeding | Low blood platelets | Headache | Liver disorder | Constipation | Nosebleeds
Alcohol Interaction: CONSULT YOUR DOCTOR
Pregnancy Interaction:
Lactation Interaction: UNSAFE
Driving Interaction:
Kidney Interaction: CONSULT YOUR DOCTOR
Liver Interaction: CAUTION